Introduction: Macrophages are central players in lung pathology with both regulatory and effector
properties. Besides activation toward the M1 subtype (classic activation), alternatively
activated M2 macrophages have been implicated in pneumonia and allergy. We investigate
the role of microRNAs in macrophage polarization-associated diseases. Here, we analyzed
the systemic RNA phenotype of murine lung macrophages in allergic airway inflammation.
We are establishing an in vitro model with bone-marrow-derived macrophages (BMMs)
to mimick the transcriptome changes which we observed here.
Methods: Macrophages from the bronchoalveolar lavage fluid (BALF) and lung homogenate of mice
with acute OVA-induced eosinophilic airway inflammation were sorted on the basis of
the CD11 and SiglecF surface markers, and total RNA was analyzed subsequently. The
transcriptome was investigated with Ingenuity Pathway Analysis to identify core regulatory
units of the OVA-induced inflammation.
Results: Differential miRNA expression could be observed that seems to be tissue- and asthma
dependent, as illustrated by principal component analysis (PCA). In the interstitial
macrophage fraction, up-regulation of the M1-associated miR-155 – 5 p and down-regulation
of the equally M1-associated miR-146a-5 p was observed, among others. On mRNA level,
prominent markers of alternative macrophage activation were found to be up-regulated,
such as Arginase (Arg1) and the IL4-induced Retnla (FIZZ1), CCL17 and Mgl2. In total,
IL-4 and IL-13 were identified as the crucial cytokines that cause the OVA-induced
transcriptome profile. We are reproducing these findings in vitro in IL-4 and Il-13
treated BMMs.
Discussion: In accordance with the TH2-skewed environment in eosinophilic airway inflammation,
we could identify IL-4 and IL-13 as decisive for the activation of macrophages upon
OVA-stimulation. We could partly reproduce this pattern by administration of IL-4
and IL-13 to BMMS. We aim to interfere with this polarization trajectory by manipulating
key miRNAs that target genes which are central for OVA-induced macrophage activation,
such as mafB and IRF4.